EarlySight

EarlySight develops Cellularis, a high-performance ophthalmic camera that provides cellular-level imaging of the retina and optic disc using adaptive optics and infrared transscleral flood illumination. The platform enables eye doctors to visualize individual cells, such as the retinal pigment epithelium and photoreceptors, to detect and monitor biomarkers for diseases like glaucoma and retinal disorders. The company is also developing AI software to analyze these images for objective structural measurement and disease progression tracking.